Tonghua Dongbao Pharmaceutical Co.,Ltd. — Investor Relations & Filings
Tonghua Dongbao Pharmaceutical Co., Ltd. specializes in the research, development, manufacturing, and distribution of pharmaceutical products, with a primary focus on diabetes care and endocrine health. The company is a leading provider of insulin products, including recombinant human insulin and various insulin analogues such as insulin glargine and insulin aspart. Its product portfolio extends to medical devices designed for diabetes management, including reusable and disposable insulin injection pens and needles. Tonghua Dongbao maintains a comprehensive R&D pipeline targeting metabolic diseases and continues to expand its production capabilities to meet growing clinical demands. The company emphasizes technological innovation in biotechnology to provide integrated solutions for blood glucose management.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 吉林秉责律师事务所关于通化东宝2025年年度股东会的法律意见书 | 2026-05-12 | Chinese | |
| 通化东宝2025年年度股东会决议公告 | 2026-05-12 | Chinese | |
| 通化东宝董事、高级管理人员薪酬管理制度（2026年4月） | 2026-04-19 | Chinese | |
| 通化东宝董事会关于独立董事独立性情况的专项意见 | 2026-04-19 | Chinese | |
| 通化东宝2025年年度报告摘要 | 2026-04-19 | Chinese | |
| 通化东宝关于以集中竞价交易方式回购公司股份实施结果暨股份变动公告 | 2026-04-10 | Chinese |
Browse filings by year
27 years- 2026 21 filings
- 2025 156 filings
- 2024 163 filings
- 2023 122 filings
- 2022 147 filings
- 2021 129 filings
- 2020 174 filings
- 2019 117 filings
- 2018 113 filings
- 2017 141 filings
- 2016 143 filings
- 2015 140 filings
- 2014 103 filings
- 2013 56 filings
- 2012 40 filings
- 2011 47 filings
- 2010 39 filings
- 2009 26 filings
- 2008 33 filings
- 2007 32 filings
- 2006 58 filings
- 2005 19 filings
- 2004 15 filings
- 2003 14 filings
- 2002 17 filings
- 2001 5 filings
- 1994 2 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 45346075 | 吉林秉责律师事务所关于通化东宝2025年年度股东会的法律意见书 | 2026-05-12 | Chinese | ||
| 45346070 | 通化东宝2025年年度股东会决议公告 | 2026-05-12 | Chinese | ||
| 41742208 | 通化东宝董事、高级管理人员薪酬管理制度（2026年4月） | 2026-04-19 | Chinese | ||
| 41742200 | 通化东宝董事会关于独立董事独立性情况的专项意见 | 2026-04-19 | Chinese | ||
| 41742193 | 通化东宝2025年年度报告摘要 | 2026-04-19 | Chinese | ||
| 41742190 | 通化东宝关于以集中竞价交易方式回购公司股份实施结果暨股份变动公告 | 2026-04-10 | Chinese | ||
| 41742182 | 通化东宝关于以集中竞价交易方式回购公司股份进展公告 | 2026-04-01 | Chinese | ||
| 41742171 | 通化东宝关于以集中竞价交易方式回购公司股份进展公告 | 2026-03-02 | Chinese | ||
| 41742168 | 通化东宝关于对吉林证监局行政监管措施决定的整改报告 | 2026-02-10 | Chinese | ||
| 41742167 | 通化东宝关于以集中竞价交易方式回购公司股份进展公告 | 2026-02-02 | Chinese | ||
| 41742164 | 通化东宝关于收到吉林证监局行政监管措施决定书的公告 | 2026-01-30 | Chinese | ||
| 41742158 | 通化东宝关于控股股东股份解押及再质押公告 | 2026-01-30 | Chinese | ||
| 41742155 | 通化东宝关于计提减值准备的公告 | 2026-01-26 | Chinese | ||
| 41742154 | 通化东宝2025年年度业绩预盈公告 | 2026-01-26 | Chinese | ||
| 41742143 | 通化东宝关于控股股东股份解押及再质押公告 | 2026-01-16 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Tonghua Dongbao Pharmaceutical Co.,Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/57070/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=57070 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=57070 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=57070 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 57070}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Tonghua Dongbao Pharmaceutical Co.,Ltd. (id: 57070)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.